VR Logo

Unrated

Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan


1 Lakh

Investment Grown to
₹ 1.51 Lakh

₹ 10000

Monthly SIP Grown to
₹ 1.61 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 43.74 -0.26 0.26 2.31 20.70 58.27 51.39 -- -- -- --
S&P BSE Healthcare TRI 47.76 -0.63 0.49 2.26 20.03 69.97 55.82 -- -- -- --
Equity: Sectoral-Pharma 52.05 -0.38 0.29 2.72 21.31 65.82 62.50 -- -- -- --
Rank within category 9 2 5 7 6 9 9 -- -- -- --
Number of funds in category 9 9 9 9 9 9 9 4 3 3 0

As on 29-Sep-2020

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
Aditya Birla Sun Life Pharma & Healthcare Fund - Direct Plan  | Invest Online
Unrated
Jul-19 51.39 -- -- 0.92 364
Nippon India Pharma Fund - Direct Plan
Unrated
Jan-13 58.85 21.37 9.05 1.31 3,653
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund - Direct Plan  | Invest Now
Unrated
Jul-18 68.96 -- -- 1.47 1,849
SBI Healthcare Opportunities Fund - Direct Plan  | Invest Online
Unrated
Jan-13 61.79 14.57 4.78 1.15 1,361
Mirae Asset Healthcare Fund - Direct Plan  | Invest Online
Unrated
Jul-18 71.02 -- -- 0.75 876

Best & Worst Performance

Best (Period) Worst (Period)
Week 20.10 (01-Apr-2020 - 09-Apr-2020) -12.20 (11-Mar-2020 - 18-Mar-2020)
Month 29.77 (25-Mar-2020 - 24-Apr-2020) -19.98 (20-Feb-2020 - 23-Mar-2020)
Quarter 38.36 (23-Mar-2020 - 22-Jun-2020) -11.14 (23-Dec-2019 - 23-Mar-2020)
Year 58.11 (19-Sep-2019 - 18-Sep-2020) 27.44 (16-Jul-2019 - 15-Jul-2020)

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -- -- -- -- -- --
S&P BSE Healthcare TRI* 14.48 23.46 0.40 0.94 -- --
Equity: Sectoral-Pharma* 17.50 20.69 0.60 1.23 0.86 4.37
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 31-Aug-2020

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 24
Top 10 Stocks (%) 62.69
Top 5 Stocks (%) 41.98
Top 3 Sectors (%) 98.01
Portfolio P/B Ratio 4.15
Portfolio P/E Ratio 40.23

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 33,760 32,978
Giant (%) 10.25 11.02
Large (%) 47.65 46.32
Mid (%) 33.85 30.77
Small (%) 8.25 11.89
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Dr. Reddy's Lab Healthcare 43.48 10.98 4.40 9.83
up Sun Pharmaceutical Inds. Healthcare 168.05 12.47 8.29 9.81
up Divi's Laboratories Healthcare 50.85 8.45 5.41 8.45
up Cipla Healthcare 37.34 10.57 4.96 8.18
up Lupin Healthcare -- 9.19 2.92 5.71
equal Metropolis Healthcare Healthcare 88.23 5.05 2.34 4.95
equal Atul Chemicals 28.58 5.95 3.67 4.25
equal Zydus Wellness FMCG 73.12 4.86 3.25 4.10
up Aurobindo Pharma Healthcare 15.68 6.47 0.00 3.74
down Cadila Healthcare Healthcare 29.90 5.89 0.00 3.68
equal Ipca Laboratories Healthcare 29.31 4.11 0.00 3.36
equal Apollo Hospitals Healthcare 153.05 6.13 3.17 3.17
equal Biocon Healthcare 79.13 4.47 2.71 3.13
up Alkem Laboratories Healthcare 24.37 5.95 2.60 2.94
equal Torrent Pharmaceuticals Healthcare 40.62 5.69 2.88 2.88
down Strides Pharma Science Healthcare 47.80 3.35 2.50 2.77
up Pfizer Healthcare 43.45 3.75 0.00 2.53
up Abbott India Healthcare 53.09 2.45 0.00 2.45
up Narayana Hrudayalaya Healthcare -- 2.37 0.00 2.37
up Sanofi India Healthcare 43.90 4.02 2.37 2.37
equal Avenue Therapeutics Inc Healthcare -- 2.30
up Fortis Healthcare (India) Healthcare -- 2.28 0.00 2.28
equal Aster DM Healthcare Healthcare 36.53 2.12 0.00 1.18
up Indoco Remedies Healthcare 61.02 1.14 0.00 0.85
down Eris Lifesciences Healthcare 23.95 3.16 0.73 0.73

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Aug-2020

Fund Manager

— Dhaval Shah since 20-Jun-2019

Education: Mr.Shah has done B.Com. from University of Mumbai & MBA from Somaiya Institute of Management Studies & Research. He also holds CFA designation.

Experience: Prior to joining Aditya Birla Sunlife Mutual Fund he has worked with HDFC Mutual Fund, Reliance Mutual Fund, Morgan Stanley.

Funds Managed:


-0.26%

Change from previous, NAV as on 29-Sep-2020

Growth: ₹ 15.5100

Dividend: ₹ 15.5100


Investment Strategy

The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.

Investment Details

Minimum Investment (₹) 1,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 500
Minimum No of Cheques 6
Minimum Withdrawal (₹) --
Minimum Balance (₹) 500
Exit Load 0.5% for redemption within 90 days

Basic Details

Fund House: Aditya Birla Sun Life Mutual Fund
Launch Date: 10-Jul-2019
Return Since Launch: 43.10%
Benchmark: S&P BSE Healthcare TRI
Riskometer: High
Type: Open-ended
Assets: ₹ 364 Cr (As on 31-Aug-2020)
Expense: 0.92% (As on 31-Aug-2020)
Risk Grade: --
Return Grade: --
Turnover: 34.00%

Contact Information

AMC: Aditya Birla Sun Life AMC Ltd.

Address: One India Bulls Center - Tower 1, 17th Floor - Jupiter Mills Compound, 841 Senapati Bhawan, Elphinstone Road, Mumbai - 400013

Phone: 022-43568000 / 1800-270-7000 / 1800-22-7000

Fax: 022-43568110

Website: http://mutualfund.adityabirlacapital.com

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

VR Helpline

IPO season

dateSaturday, 03-Oct-2020
time04:00 PM - 04:30 PM